相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Molecular Mechanisms of Colon Cancer Progression and Metastasis: Recent Insights and Advancements
Ahmed Malki et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
The Cuban Propolis Component Nemorosone Inhibits Proliferation and Metastatic Properties of Human Colorectal Cancer Cells
Yahima Frion-Herrera et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Western Diet-Induced Metabolic Alterations Affect Circulating Markers of Liver Function before the Development of Steatosis
Daniela Gabbia et al.
NUTRIENTS (2019)
Nemorosone inhibits the proliferation and migration of hepatocellular carcinoma cells
Yahima Frion-Herrera et al.
LIFE SCIENCES (2019)
Dexamethasone counteracts hepatic inflammation and oxidative stress in cholestatic rats via CAR activation
Daniela Gabbia et al.
PLOS ONE (2018)
Intracrine VEGF signalling mediates colorectal cancer cell migration and invasion
Rajat Bhattacharya et al.
BRITISH JOURNAL OF CANCER (2017)
Antibody drug conjugates: lessons from 20 years of clinical experience
A. W. Tolcher
ANNALS OF ONCOLOGY (2016)
p28-Mediated Activation of p53 in G2-M Phase of the Cell Cycle Enhances the Efficacy of DNA Damaging and Antimitotic Chemotherapy
Tohru Yamada et al.
CANCER RESEARCH (2016)
Drug and protein delivery by polymer conjugation
Antonella Grigoletto et al.
JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY (2016)
TIMP1 is a prognostic marker for the progression and metastasis of colon cancer through FAK-PI3K/AKT and MAPK pathway
Guohe Song et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2016)
A folate receptor-targeted lipoplex delivering interleukin-15 gene for colon cancer immunotherapy
Xiao Liang et al.
ONCOTARGET (2016)
The Role of Matrix Metalloproteinases in Colorectal Cancer
Anan H. Said et al.
CANCERS (2014)
CD133 Affects the Invasive Ability of HCT116 Cells by Regulating TIMP-2
Min Zhang et al.
AMERICAN JOURNAL OF PATHOLOGY (2013)
Poly(ethylene glycol)-paclitaxel-alendronate self-assembled micelles for the targeted treatment of breast cancer bone metastases
Keren Miller et al.
BIOMATERIALS (2013)
Carcinoembryonic antigen is the preferred biomarker for in vivo colorectal cancer targeting
J. P. Tiernan et al.
BRITISH JOURNAL OF CANCER (2013)
Matrix Metalloproteinase-2 Cleavage of the β1 Integrin Ectodomain Facilitates Colon Cancer Cell Motility
Jakub Kryczka et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Serous ovarian carcinoma patients with high alpha-folate receptor had reducing survival and cytotoxic chemo-response
Yu-Li Chen et al.
MOLECULAR ONCOLOGY (2012)
Folate receptor-α expression in resectable hepatic colorectal cancer metastases: patterns and significance
Michael D'Angelica et al.
MODERN PATHOLOGY (2011)
Dendritic Poly(ethylene glycol) Bearing Paclitaxel and Alendronate for Targeting Bone Neoplasms
Chiara Clementi et al.
MOLECULAR PHARMACEUTICS (2011)
Fluvoxamine pharmacokinetics in healthy elderly subjects and elderly patients with chronic heart failure
Rocco Orlando et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2010)
Relevance of folic acid/polymer ratio in targeted PEG-epirubicin conjugates
Fabiana Canal et al.
JOURNAL OF CONTROLLED RELEASE (2010)
Polymer-Drug Conjugates for Combination Anticancer Therapy: Investigating the Mechanism of Action
Gianfranco Pasut et al.
JOURNAL OF MEDICINAL CHEMISTRY (2009)
Antitumoral activity of PEG-gemcitabine prodrugs targeted by folic acid
Gianfranco Pasut et al.
JOURNAL OF CONTROLLED RELEASE (2008)
Mechanism of G1-like arrest by low concentrations of paclitaxel: next cell cycle p53-dependent arrest with sub G1 DNA content mediated by prolonged mitosis
Z. N. Demidenko et al.
ONCOGENE (2008)
Nitric oxide modulates proapoptotic and antiapoptotic properties of chemotherapy agents: the case of NO-pegylated epirubicin
Luca Santucci et al.
FASEB JOURNAL (2006)
Arming antibodies: prospects and challenges for immunoconjugates
AM Wu et al.
NATURE BIOTECHNOLOGY (2005)
Targeted drug delivery via the folate receptor
J Sudimack et al.
ADVANCED DRUG DELIVERY REVIEWS (2000)
Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review
H Maeda et al.
JOURNAL OF CONTROLLED RELEASE (2000)